Synthetic biology. It sounds like something from a sci-fi movie, or an oxymoron like jumbo shrimp or clearly confused. After all, biology is the study of living organisms. And synthetic means made by chemical synthesis, especially to imitate a natural product. But synthetic biology has real potential to replace costly or unsustainable manufacturing processes and solve pressing global challenges, and Ginkgo Bioworks is on it.
We got wind that Massachusetts-based Ginkgo Bioworks, referred to as "the organism company," that is using advanced biotechnology to grow products instead of manufacturing them, got a Series E financing round of $290 million bringing the company's total funding to $719 million . You got that right, $719 million total.
No comments:
Post a Comment